Future developments will likely include expanded insurance coverage , wider adoption of AI-driven care models , and the rise of combination and oral therapies that improve patient convenience without compromising efficacy
What remains intriguing is this: after so many hard lessons learned from building around GLP-1 (the peptide of the decade) many founders still don't recognize that healthcare demands certain non-negotiable considerations: technology, regulation, and clinical expertise
The research indicates that those using Ozempic may be more than twice as likely to develop NAION compared to patients taking other diabetes medications
You dont need a complicated routinejust something you can use daily and stay consistent with
Lefty is the daughter of Eric Lefkofsky, co-founder of Groupon and founder and CEO of healthcare startup Tempus AI, who Forbes estimates is worth $4.8 billion as of Wednesday
Ro and Henry Meds have emerged as prominent telehealth intermediaries for GLP-1 prescription access, collectively serving hundreds of thousands of patients seeking weight management and metabolic support